Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (238)	6/7/1998 5:52:00 PM
From: Anthony Wong	Respond to of 1722

BR, I think you're correct in your assumption (that those countries who honor patents would not allow companies in their country to buy the drug from these rip-off artists). We can write off sales from those countries that do not respect patents (India, China, and some S. American countries). There's not much that Pfizer or any other pharmaceutical company can do in cases like this. LLY is still fighting in the Chinese court system about generic versions of Prozac in China.